Home-based visual training guided by brain imaging for vision loss after stroke
Tests two kinds of home visual training in adults with visual field loss.
Plain-language title generated from the registry record
Registry title: Home-based Vision Rehabilitation Guided by Brain Imaging
Key facts
- Where
- Washington D.C., United StatesSee the site
Where in United States
- Georgetown University Medical CenterWashington D.C., United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Georgetown University
- Trial code
- NCT07635329
- Record updated
- 14 September 2026
- Original description
The BRIGHT (Behavioral Rehabilitation Through Image-Guided Home-based Training) study aims to evaluate the effectiveness of image-guided, home-based perceptual training at improving visual performance in individuals with visual field loss.Read full original descriptionShow less
Behavioral Rehabilitation Through Image-Guided Home-based Training
The BRIGHT (Behavioral Rehabilitation Through Image-Guided Home-based Training) study aims to evaluate the effectiveness of image-guided, home-based perceptual training at improving visual performance in individuals with visual field loss.
Using a prospective, crossover design, BRIGHT combines visual behavioral testing, neuroimaging, and a home-based intervention. It aims to 1) identify neural pathways that support training-induced visual plasticity; and 2) compare the efficacy of different types of visual training delivered in a home-based setting.
Inclusion: At least 18 years of age; Capable of providing informed consent and complying with study procedures; Unilateral or bilateral focal brain damage causing visual field loss; At least three months post-stroke or traumatic brain injury, or a stable brain tumor within the past year; Eligible for MRI based on standard safety screening.
Exclusion: Current or recent (within the past 6 months) drug or alcohol abuse or addiction as defined by DSM-5; Severe neurological or psychiatric conditions unrelated to the focal lesion that may interfere with study participation or data interpretation; Ocular disease or disorder.